Teladoc Health Inc. (NYSE:TDOC) changes shares on Friday trading session, with a change of 4.97% or $9.55 shares. The trading starts at $192.96 and closed at $191.98 throughout the day. The trading session low price was $192.50 and day high was $203.46 on Friday, June 19. After the session, the Healthcare sector daily volume shifted to 4.82 million while its average volume is 3.42M. In other hand, the TDOC market cap reached to $15.13B. While, its current target price is $201.53 according to WSJ.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 16.98% and up 17.67% for month. Its quarterly performance was 42.18% above, while its half year performance is up 148.99%. TDOC yearly performance stood at positive 221.06% and rise 140.72% for year-to-date. Current recommendation for Teladoc Health Inc. is 2.30.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. TDOC EPS (TTM) for 12-month is -1.36. EPS for this year is 6.70%, while for the next year its value is -0.59. Its EPS Q/Q reached 5.00%. It has an EPS of 33.10% up for past five years and for the next five years will be up 20.00%.
Let’s take a look on the analyst recommendations on TDOC for the current month and previous month. For the current month, 10 of 24 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 1 as underweight and 13 as Hold. As compared with the previous month ratings, 24 analysts participate in stock recommendation. Out of 24, 0 rated it sell, 11 rated it as Buy and 12 as Hold Ratings. On the other hand, target price ranges from $135.00-$220.00. Average target price for TDOC was reached at $179.27.
Blackrock Inc., Vanguard Group, Inc. (The) and Baillie Gifford and Company are the top three holders in Teladoc Health Inc. (TDOC) stock. On Mar 30, 2020, Blackrock Inc. has 7.59 million shares which valued 1.18 billion. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 6.83 million shares which valued at 1.06 billion. On Mar 30, 2020, Baillie Gifford and Company has a total of 5.77 million shares which valued at 895.03 million. In the end, Baillie Gifford and Company have 7.76% shares outstanding of Teladoc Health Inc. (TDOC) on Mar 30, 2020. The insider ownership moved to 1.10%.
The company posted an EPS (TTM) of -1.36. According to the most recent quarter report on (Jun 2020), 22 analysts estimated an average EPS of -0.24, while -0.41 EPS posted a year ago period. Analyst Estimated EPS for TDOC published in the report was -0.28–0.2 during the same period. Comparing with last year, the average estimated EPS was -0.41 which is lower than -0.4 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for TDOC rise 76.57% for period of 200 days. SMA for 50 days was 15.87% which is showing green signal, while SMA-20 was 16.40%. The moving average value for Teladoc Health Inc. (TDOC) is 133.96 and 175.74 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in TDOC stock. On Jun 17, Verstraete Stephany, Chief Marketing Officer, sold 2,000 trading shares at the cost of $190.00, which valued at 0.38 million. On Jun 17, Frist William H., Director, sold 740 shares at the cost of $190.00, with total shares of 5,418. On Jun 17, SHEDLARZ DAVID L, Director, sold 9,127 shares at the cost of 189.00. After this transaction, SHEDLARZ DAVID L total shares reached to 3,930 which valued at 1.73 million.